<DOC>
	<DOCNO>NCT00223184</DOCNO>
	<brief_summary>At present , recognise prognostic factor primary high-grade osteosarcoma histological response preoperative chemotherapy . Our study design identify new diagnostic marker could eventually prognostic value therapeutic consequence . 80 patient 20 year age primary osteosarcomas study treatment French Society Paediatric Oncology OS 94 protocol . Paired normal biopsy sample collect . In addition , surgical resection specimen , follow preoperative chemotherapy , obtain many case . After genomic DNA extraction , allelotyping analysis target microsatellites plan . The studied DNA region contain mainly Rb , p53 , APC , p16 , c-met , TWIST , c-kit , erbB2 topoisomerases gene . The technique use molecular analysis comprise mainly allelotyping study , quantitative real-time PCR , gene sequencing , immunohistochemistry . The first result show prognostic value 7q31 region contain c-met 5q21 contain APC ( Br J Cancer , 2003 , Entz-Werlé et al . ) , 7p21 contain TWIST ( Int J Cancer , 2005 , Entz-Werlé et al . ) 4q21 target c-kit gene ( J Clin Oncol , 2005 , Entz-Werlé et al . ) .</brief_summary>
	<brief_title>Genetic Characterisation High-grade Paediatric Osteosarcomas</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>Patients 20 year age primary osteosarcoma Under treatment French Society Paediatric Oncology OS 94 protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>